Page 1533 - Small Animal Internal Medicine, 6th Edition
P. 1533

CHAPTER 97   Polysystemic Mycotic Infections  1505


            been the drug of choice for the treatment of blastomycosis   COCCIDIOIDOMYCOSIS
            (see Table 97.2). Dogs should be treated with 5 mg/kg/day   Etiology and Epidemiology
  VetBooks.ir  twice daily for the first 5 days and then 5 mg/kg once daily.   Coccidioides immitis is a dimorphic fungus found deep in
            Treatment should be continued for 60 to 90 days or for 4
            weeks beyond resolution of measurable disease (i.e., thoracic
                                                                 fall, and high environmental temperatures, including the
            radiographic abnormalities  or skin  lesions).  A bioequiva-  sandy alkaline soils in regions with low elevation, low rain-
            lence study showed that generic intraconazole was not bio-  southwestern United States, California, Mexico, Central
            equivalent to the approved product but was close enough to   America, and South America. In the United States coccidi-
            be used clinically (Mawby et al., 2014). In contrast, one   oidomycosis  is diagnosed  most frequently  in California,
            source of compounded itraconazole was not suitable for use.   Arizona, New Mexico, Utah, Nevada, and southwest Texas.
            Fluconazole can also be used and may be effective for CNS,   Coccidioides posadasii has also been proven in some regions
            ocular, and urinary system blastomycosis. In one retrospec-  that are endemic for C. immitis (Brown et al., 2013; Luna-
            tive study, overall responses to fluconazole or itraconazole in   Isaac  et al.,  2014). The  environmental mycelial  phase pro-
            dogs with blastomycosis were similar. However, dogs treated   duces arthrospores (2-4 µm wide, 3-10 µm long) that enter
            with fluconazole had a higher mortality rate in the first 2   the vertebrate host by inhalation or wound contamination.
            weeks of therapy, suggesting differences between the drugs   Large numbers of arthrospores return to the surface after
            in early efficacy (Mazepa et al., 2011).             periods of rainfall and are dispersed by the wind; the preva-
              Relapses occur in 20% to 25% of treated dogs. When they   lence of coccidioidomycosis increases in the years after a
            occur, a complete course of therapy should be reinstituted.   high rainfall. Most cases of feline coccidioidomycosis are
            Posterior segment ocular disease responds well to itracon-  diagnosed between December and May. In one study of dogs
            azole, but anterior uveitis and endophthalmitis often require   residing in an endemic area (Arizona), the cumulative prob-
            enucleation of the affected eye. In dogs with ocular blasto-  ability of infection (evidenced by seroconversion) by 2 years
            mycosis resulting in euthanasia or enucleation of the affected   of age was 28%, and the cumulative probability of clinical
            eye, differences in the presence of the organism was not   infection by 2 years of age was 6% (Shubitz et al., 2005). In
            noted between treated and untreated dogs (Hendrix et al.,   another recent study that included 41 dogs with coccidioi-
            2004). In one study of 23 cats with blastomycosis, successful   domycosis and 79 control dogs, younger age, digging behav-
            results were reported for two cats treated with amphotericin   ior, and travel to Arizona or the California central valley
            B and ketoconazole, one cat treated with amputation, and   were associated with infection (Gayzel et al., 2017).
            one cat treated with potassium iodide. In a more recent study   Inhaled arthrospores induce neutrophilic inflamma-
            of eight cats, two cats treated with itraconazole and one cat   tion followed by infiltrates of histiocytes, lymphocytes, and
            treated with fluconazole had clinical resolution of their   plasma  cells. The  lymphocytic infiltrates  associated  with
            disease (Gilor et al., 2006).                        infection sites are predominantly T cells. Infection is cleared
              After treatment, decreases in B. dermatitidis serum anti-  if cell-mediated immune responses are normal; most people,
            body levels are variable. In contrast, in one study of 46   dogs, and cats exposed to the organism are subclinically
            treated dogs, urine antigen concentrations decreased with   affected. The organism disseminates to mediastinal and
            treatment and so may be of benefit for monitoring therapy   tracheobronchial lymph nodes, bones and joints, visceral
            with clinical and radiographic parameters (Spector et al.,   organs (liver, spleen, kidneys), heart and pericardium, testi-
            2008).                                               cles, eyes, brain, and spinal cord of some individuals. Spher-
                                                                 ules (20-200 µm in diameter) containing endospores (see
            Zoonotic Aspects and Prevention                      Table 97.1) form in tissues of infected hosts. Endospores are
            Genetic analyses have confirmed three haplotypes of B. der-  released by cleavage and produce new spherules. Respiratory
            matitidis that are common to both dogs and humans (Ander-  signs and signs of disseminated disease occur 1 to 3 weeks
            son et al., 2013). Direct zoonotic transmission from infected   and 4 months after exposure, respectively.
            animals is unlikely because the yeast phase is not as infec-
            tious as the mycelial phase. One veterinarian was infected   Clinical Features
            after material from a pulmonary aspirate from an infected   Clinical disease in dogs is most common in young, male,
            dog was injected intramuscularly, and another developed   large-breed dogs. Dogs that are allowed to roam or walk in
            disease after being bitten by an infected dog. The mycelial   the desert in endemic areas, particularly if they also exhibit
            phase develops at temperatures lower than body tempera-  digging behavior are  most  likely  to be  exposed.  Approxi-
            ture; positive cultures and contaminated bandages are infec-  mately 90% of clinically affected dogs have lameness with
            tious. Multiple reports have been made of canine and human   swollen, painful bones or joints. Cough, dyspnea, anorexia,
            blastomycosis that developed from the same environmental   weakness, weight loss, lymphadenopathy, clinical signs of
            exposure. Decreasing potential for exposure by avoiding   ocular inflammation, and diarrhea are other presenting
            lakes and creeks in endemic areas is the only way to prevent   complaints. Crackles, wheezes, or muffled lung sounds
            the disease. A vaccine made of a genetically engineered live-  from pleural effusion are common. Restrictive pericardi-
            attenuated strain of B. dermatitidis shows promise for use in   tis presenting with evidence of right heart failure, such as
            dogs (Wüthrich M et al., 2011).                      hepatomegaly, pleural effusion, and ascites, can also occur.
   1528   1529   1530   1531   1532   1533   1534   1535   1536   1537   1538